Peak Pharmaceuticals, Inc. filed its 10-K on Jan 12, 2018 for the period ending Sep 30, 2017. In this report its auditor, Dale Matheson Carr-Hilton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.